Free Trial
OTCMKTS:GSTC

GlobeStar Therapeutics (GSTC) Stock Price, News & Analysis

$0.0002 0.00 (0.00%)
As of 04/21/2025

About GlobeStar Therapeutics Stock (OTCMKTS:GSTC)

Key Stats

Today's Range
$0.0002
$0.0002
50-Day Range
N/A
52-Week Range
$0.0001
$0.0012
Volume
35 shs
Average Volume
3.16 million shs
Market Capitalization
$248,221.20
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

GlobeStar Therapeutics Corporation, a clinical stage pharmaceutical company, focuses on developing a patented formulation of drugs for the treatment of multiple sclerosis and other neurodegenerative diseases. It offers Amethyst, a compound intended to treat neurodegeneration. The company was formerly known as AngioSoma, Inc. and changed its name to GlobeStar Therapeutics Corporation in July 2021. GlobeStar Therapeutics Corporation is based in Richland, Washington.

Receive GSTC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GlobeStar Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

GSTC Stock News Headlines

Trump’s betrayal exposed
Fair warning: this will not make for easy viewing. Especially if you voted for Trump, put your faith in him, and have any exposure to stocks, real estate, or crypto. But do not ignore this, as there’s likely nothing more important to your financial security in 2025.
KHTRF Knight Therapeutics Inc.
GlobeStar Therapeutics Corp GSTC
See More Headlines

GSTC Stock Analysis - Frequently Asked Questions

GlobeStar Therapeutics' stock was trading at $0.0003 at the beginning of the year. Since then, GSTC stock has decreased by 33.3% and is now trading at $0.0002.
View the best growth stocks for 2025 here
.

Shares of GSTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that GlobeStar Therapeutics investors own include Arrival (ARVL), Cosmos Health (COSM), COMSovereign (COMS), Good Hemp (GHMP), Meta Materials (MMTLP), Palisade Bio (PALI) and Sintx Technologies (SINT).

Company Calendar

Today
4/22/2025
Fiscal Year End
9/30/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:GSTC
Fax
N/A
Employees
1
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-1,950,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
1,241,106,000
Free Float
1,210,078,000
Market Cap
$248,221.20
Optionable
Not Optionable
Beta
1.95
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (OTCMKTS:GSTC) was last updated on 4/22/2025 by MarketBeat.com Staff
From Our Partners